AstraZeneca announces $50 billion investment in the United States
World Business Report
00:00
AstraZeneca's $50 Billion Investment: Shaping Pharma's Future
This chapter explores AstraZeneca's landmark $50 billion investment in the U.S., signaling a strategic shift in the pharmaceutical industry. It examines the implications for British manufacturing, competitive dynamics with China, and the evolving trade agreements amid tariffs. The discussion also highlights growth opportunities in biopharmaceuticals, the role of artificial intelligence in drug development, and challenges presented by international trade policies.
Transcript
Play full episode
